Tanya N Soliman (Tanya Soliman)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Cancer research

Nature communications

The Journal of cell biology

Nature reviews. Cancer

Barts Cancer Institute

University of Queensland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Barts Cancer Institute Jun 01 2020

United Kingdom

Group Leader :: Centre for Genomics and Computational Biology

Barts Cancer Institute Jun 15 2019

United Kingdom

Postdoctoral Research Scientist :: Centre for Molecular Oncology

Education History

University of Queensland

Australia

PHD :: Diamantina Institute

University of Queensland

Australia

BSC

University of Queensland

Australia

BSC

Publications

Tanya N Soliman, Daniel Keifenheim, Peter J Parker, Duncan J Clarke
Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications. The Journal of cell biology 222 (12) (2023)
Nicola Lockwood, Silvia Martini, Ainara Lopez-Pardo, Katharina Deiss, Hendrika A Segeren, Robert K Semple, Ian Collins, Dimitra Repana, Mathias Cobbaut, Tanya N Soliman, Francesca Ciccarelli, Peter J Parker
Genome-Protective Topoisomerase 2a-Dependent G2 Arrest Requires p53 in hTERT-Positive Cancer Cells. Cancer research 82 (9) (2022)
Joanna R Kelly, Silvia Martini, Nicola Brownlow, Dhira Joshi, Stefania Federico, Shirin Jamshidi, Svend Kjær, Nicola Lockwood, Khondaker Miraz Rahman, Franca Fraternali, Peter J Parker, Tanya N Soliman
Author Correction: The Aurora B specificity switch is required to protect from non-disjunction at the metaphase/anaphase transition. Nature communications 11 (1) (2020)
Joanna R Kelly, Silvia Martini, Nicola Brownlow, Dhira Joshi, Stefania Federico, Shirin Jamshidi, Svend Kjær, Nicola Lockwood, Khondaker Miraz Rahman, Franca Fraternali, Peter J Parker, Tanya N Soliman
The Aurora B specificity switch is required to protect from non-disjunction at the metaphase/anaphase transition. Nature communications 11 (1) (2020)
Naoka Tamura, Nadeem Shaikh, Daniel Muliaditan, Tanya N Soliman, Jennifer R McGuinness, Eleni Maniati, Daniella Moralli, Mary-Anne Durin, Catherine M Green, Frances R Balkwill, Jun Wang, Kit Curtius, Sarah E McClelland
Specific Mechanisms of Chromosomal Instability Indicate Therapeutic Sensitivities in High-Grade Serous Ovarian Carcinoma. Cancer research 80 (22) (2020)
Peter J Parker, Sophie J Brown, Veronique Calleja, Probir Chakravarty, Mathias Cobbaut, Mark Linch, Jacqueline J T Marshall, Silvia Martini, Neil Q McDonald, Tanya N Soliman, Lisa Watson
Equivocal, explicit and emergent actions of PKC isoforms in cancer. Nature reviews. Cancer 21 (1) (2020)
Jeroen Claus, Gargi Patel, Flavia Autore, Audrey Colomba, Gregory Weitsman, Tanya N Soliman, Selene Roberts, Laura C Zanetti-Domingues, Michael Hirsch, Francesca Collu, Roger George, Elena Ortiz-Zapater, Paul R Barber, Boris Vojnovic, Yosef Yarden, Marisa L Martin-Fernandez, Angus Cameron, Franca Fraternali, Tony Ng, Peter J Parker
Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface. eLife 7 (2018)

Tanya N Soliman.css-eqlu8i{font-size:small;padding-left:4px;} (Tanya Soliman)

Publication Activity (10 Years)

Top Topics

Top Venues

Tanya N Soliman (Tanya Soliman)